ALICIA THEILEN: Open Payments
NPI 1194179903 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 26 payments from 6 companies in 2025. Trend: 2023 $458 · 2024 $1,132 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $307 |
| Vanda Pharmaceuticals Inc. | 5 | $297 |
| Axsome Therapeutics, Inc. | 4 | $180 |
| Collegium Pharmaceutical, Inc. | 5 | $90 |
| Almatica Pharma LLC | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: CAPLYTA, FANAPT, Auvelity, Jornay PM, HETLIOZ, LOREEV XR, Qelbree.
Industry payments across NE — which companies pay providers there.
